Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Platelet-derived growth factor receptor beta (PDGFRβ) is a cell surface receptor tyrosine kinase that plays a critical role in cellular signaling, particularly in processes such as cell proliferation, migration, survival, and differentiation. It is essential for normal cardiovascular development, blood vessel formation (angiogenesis), and early hematopoiesis. Mutations or chromosomal rearrangements involving PDGFRB can result in various pathologies, including myeloproliferative neoplasms and leukemia. Abnormal activation has been implicated broadly across diseases characterized by abnormal cell proliferation or fibrosis.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet-derived Growth Factor Beta Receptor (PDGFRβ).